Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Market Movers
TipRanks Momentum Index
Dividend Stocks
AI Stocks
Largest Companies by Market Cap
ETFs
Top ETFs by Upside
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Ideas
Research Tools
Trending Stocks
Compare Stocks
Compare ETFs
Most Visited Websites
Daily Feeds
Daily Analyst Ratings
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Economic Indicators
Inflation Rate
Unemployment Rate
Class Actions
Tools
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Screeners
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Dividends
My Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Experts
Portfolio
News
Enterprise Solutions
Education
Personal Finance
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Advertise with Us
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
More
Plans
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Screeners
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Ideas
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Research Tools
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Calculators
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividends
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Market Movers
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Calculators
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Plans & Pricing
More
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Log Out
CDTX
Stock Latest News
The Fly
Elicio Therapeutics appoints Preetam Shah as chief strategy, financial officer
11d ago
CDTX
ELTX
Premium
Ratings
Positive Buy Rating for Cidara Therapeutics Driven by Promising CD388 Development and Safety Profile
17d ago
CDTX
Premium
The Fly
Cidara Therapeutics to present on CD388 at ICAR 2025
17d ago
CDTX
Premium
The Fly
Cidara Therapeutics: CD388 preclinical data published in Nature Microbiology
18d ago
CDTX
Premium
The Fly
Cidara Therapeutics initiated with an Outperform at Citizens JMP
24d ago
CDTX
Premium
Ratings
Buy Rating for Cidara Therapeutics: Promising Potential of CD388 in Influenza Prevention
24d ago
CDTX
Premium
Ratings
Ed Arce’s Buy Rating for Cidara Therapeutics Driven by Accelerated CD388 Program and Promising Phase 2b NAVIGATE Study Developments
25d ago
CDTX
Premium
The Fly
Cidara Therapeutics price target raised to $35 from $24 at H.C. Wainwright
25d ago
CDTX
Premium
Company Announcements
Cidara Therapeutics Faces Financial Risks Amid Delayed Annual Report Filing
28d ago
CDTX
Premium
Company Announcements
Cidara Therapeutics Advances with Strong Financial Backing
28d ago
CDTX
Premium
Ratings
Buy Rating for Cidara Therapeutics Driven by Phase 2b Trial Progress and Strong Financial Position
28d ago
CDTX
Premium
The Fly
Cidara Therapeutics reports Q4 EPS ($5.37) vs. (71c) last year
29d ago
CDTX
Premium
The Fly
Six new option listings and one option delisting on February 26th
1M ago
PAL
BZAI
Premium
Company Announcements
Cidara Therapeutics Announces CFO Transition
1M ago
8K
CDTX
Premium
The Fly
Cidara Therapeutics appoints Karbe as CFO
2M ago
CDTX
Premium
The Fly
Cidara Therapeutics assumed with an Overweight at Cantor Fitzgerald
2M ago
CDTX
Premium
Company Announcements
Cidara Therapeutics Announces Leadership Changes and Appointments
3M ago
8K
CDTX
Premium
The Fly
Biotech Alert: Searches spiking for these stocks today
3M ago
ACAD
BHVN
Premium
The Fly
Biotech Alert: Searches spiking for these stocks today
3M ago
CVM
CDTX
Premium
The Fly
Cidara Therapeutics files to sell 7.04M shares of common stock for holders
3M ago
CDTX
Premium
The Fly
Twelve option delistings on December 23rd
3M ago
ATRA
BURU
Premium
The Fly
Cidara Therapeutics initiated with an Outperform at RBC Capital
4M ago
CDTX
Show More
Trending
Indices
Stocks
ETFs
Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >
You need to enable JavaScript to run this app.